Wakelee HA - Search Results

1

Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.

Moding EJ, Liu Y, Nabet BY, Chabon JJ, Chaudhuri AA, Hui AB, Bonilla RF, Ko RB, Yoo CH, Gojenola L, Jones CD, He J, Qiao Y, Xu T, Heymach JV, Tsao A, Liao Z, Gomez DR, Das M, Padda SK, Ramchandran KJ, Neal JW, Wakelee HA, Loo BW Jr, Lin SH, Alizadeh AA, Diehn M. Moding EJ, et al. Among authors: wakelee ha. Nat Cancer. 2020 Feb;1(2):176-183. doi: 10.1038/s43018-019-0011-0. Epub 2020 Jan 20. Nat Cancer. 2020. PMID: 34505064 Free PMC article.

2

Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.

Wakelee HA, Sikic BI. Wakelee HA, et al. Clin Lung Cancer. 2005 Sep;7 Suppl 1:S6-12. doi: 10.3816/clc.2005.s.002. Clin Lung Cancer. 2005. PMID: 16159420 Review.

3

Second- and third-line treatments in non-small cell lung cancer.

Kumar A, Wakelee H. Kumar A, et al. Curr Treat Options Oncol. 2006 Jan;7(1):37-49. doi: 10.1007/s11864-006-0030-9. Curr Treat Options Oncol. 2006. PMID: 16343367 Review.

4

An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.

Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ. Le QT, et al. Clin Cancer Res. 2006 Mar 1;12(5):1507-14. doi: 10.1158/1078-0432.CCR-05-2049. Clin Cancer Res. 2006. PMID: 16533775 Free article.

5

Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.

Wakelee HA, Bernardo P, Johnson DH, Schiller JH. Wakelee HA, et al. Cancer. 2006 May 15;106(10):2208-17. doi: 10.1002/cncr.21869. Cancer. 2006. PMID: 16604529 Free article.

6

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Wakelee HA, Schiller JH, Gandara DR. Wakelee HA, et al. Clin Lung Cancer. 2006 Jul;8(1):18-21. doi: 10.3816/CLC.2006.n.028. Clin Lung Cancer. 2006. PMID: 16870041 Review.

7

A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma.

Roy MS, Le QT, Donington JS, Wakelee HA. Roy MS, et al. Among authors: wakelee ha. Clin Lung Cancer. 2006 Sep;8(2):146-8. doi: 10.3816/CLC.2006.n.044. Clin Lung Cancer. 2006. PMID: 17026817

8

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH; Eastern Cooperative Oncology Group. Wakelee HA, et al. J Thorac Oncol. 2006 Jun;1(5):441-6. J Thorac Oncol. 2006. PMID: 17409897 Free article. Clinical Trial.

9

Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.

Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Le QT, et al. J Thorac Oncol. 2006 Oct;1(8):802-9. J Thorac Oncol. 2006. PMID: 17409963 Free article. Clinical Trial.

10

Metabolic tumor burden predicts for disease progression and death in lung cancer.

Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW Jr. Lee P, et al. Among authors: wakelee ha. Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):328-33. doi: 10.1016/j.ijrobp.2007.04.036. Int J Radiat Oncol Biol Phys. 2007. PMID: 17869659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

338 results

Search Page